FREE ACCESS

Sign in with Google to continue in IP News.

Google SSO gives you the quickest path into the IIPLA newsroom, your reading access, and member-level continuity across articles. The full login page is still available if you prefer another option.

By continuing you agree to our terms and privacy policy.

Already have an account? Log in · Create account

Members-only content

IIPLA News
Saturday, May 2, 2026

Zydus Lifesciences Resolves Myrbetriq Patent Litigation with Astellas Through $120 Million Settlement

Settlement grants Zydus continued US market access for generic Mirabegron and includes ongoing licensing fees through 2027.

IIPLA News Deskanonymous access0 articles left this week
Zydus Lifesciences Resolves Myrbetriq Patent Litigation with Astellas Through $120 Million Settlement
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

Zydus Lifesciences Limited has finalized a comprehensive settlement with Astellas Pharma Inc., ending all US patent disputes over the bladder drug Myrbetriq (Mirabegron). The agreement requires Zydus to pay $120 million plus ongoing licensing fees until September 2027, allowing the company to continue marketing its ge…
Related Coverage

Continue in the newsroom

Back to newsroom
PatentsMiddle East

Kuwait’s Intellectual Property Sector Yields KD 6.69 Million in Fees Amid Rising Activity

Kuwait’s Ministry of Commerce and Industry has announced robust growth in intellectual property services, with the Trademarks and Patents Department recording 68,632 transactions in 2025, generating approximately KD 6.69 million ($21.7 million) in fees. This surge reflects the government’s strategic initiatives to bol…

Wednesday, May 13, 2026
PatentsUSA

Supreme Court Declines Review in Rapunzel Doll Trademark Opposition Case

The U.S. Supreme Court has denied a petition for certiorari filed by Rebecca Curtin, a consumer and law professor, who sought to oppose the trademark registration of "RAPUNZEL" for dolls and toy figures. The decision leaves intact the Federal Circuit's ruling that consumers lack statutory standing under 15 U.S.C. § 10…

Wednesday, May 13, 2026